Introduction: The Controversy Around Obesity Drugs and the NHS The emergence of GLP-1 obesity medications — often referred to by the nickname “skinny jabs” — has sparked a heated policy debate in the UK. Proponents say these drugs can be life-changing, helping people reduce weight and improve health. Critics argue that funding should be reserved…